Clinical Significance of the Serotonin Release Assay and Platelet Count Monitoring After Cardiac Surgery
- PMID: 29046071
- PMCID: PMC6714719
- DOI: 10.1177/1076029617734308
Clinical Significance of the Serotonin Release Assay and Platelet Count Monitoring After Cardiac Surgery
Abstract
Heparin-induced thrombocytopenia (HIT) is one of the serious complications in patients who undergo cardiac surgery. However, there remains a major problem in diagnosing HIT because the current immunological assays for detection of HIT antibody have limitations. Furthermore, the clinical course of thrombocytopenia in this surgery makes it increasingly difficult to diagnose HIT. We investigated the relationship between platelet count and HIT antibody in 59 patients who underwent cardiac surgery using cardiopulmonary bypass (CPB). The number of postoperative HIT antibody-positive patients evaluated using enzyme-linked immunosorbent assay kit (polyanion IgG/IgA/IgM complex antibodies/antiplatelet factor 4 enhanced) was 37 (62.7%). In contrast, platelet activation by HIT antibody was evaluated using the serotonin release assay (SRA). More than 20% and 50% release of serotonin was obtained from 12 patients (20.3%) and 8 patients (13.6%), respectively. The levels of d-dimer were significantly different on postoperative day 14 between SRA-positive and SRA-negative groups; however, postoperative thrombus complication was not detected using sonography in the patients with positive serotonin release at all. After being decreased by the operation, their platelet count recovered within 2 weeks in both groups equally. In our study, although the patients were positive in the platelet activating HIT antibody assay, they remained free from thrombosis and their platelet count recovered after early postoperative platelet decrease. Therefore, in addition to the SRA, monitoring of platelet count might be still considered an indispensable factor to facilitate the prediction of HIT thrombosis prior to manifestation in the patients undergoing cardiac surgery using CPB.
Keywords: cardiac surgery; cardiopulmonary bypass; heparin-induced thrombocytopenia; platelet count monitoring; serotonin release assay.
Conflict of interest statement
Figures
Similar articles
-
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.Chest. 2018 Jun;153(6):1396-1404. doi: 10.1016/j.chest.2018.01.001. Epub 2018 Jan 8. Chest. 2018. PMID: 29325985
-
A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.Anesth Analg. 2011 Oct;113(4):697-702. doi: 10.1213/ANE.0b013e3182297031. Epub 2011 Jul 25. Anesth Analg. 2011. PMID: 21788317
-
Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.Br J Haematol. 2017 Dec;179(5):811-819. doi: 10.1111/bjh.14955. Epub 2017 Oct 19. Br J Haematol. 2017. PMID: 29048130
-
Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review.Platelets. 2017 Sep;28(6):614-620. doi: 10.1080/09537104.2017.1366973. Epub 2017 Aug 31. Platelets. 2017. PMID: 28856946 Review.
-
Laboratory diagnosis of heparin-induced thrombocytopenia.Int J Lab Hematol. 2019 May;41 Suppl 1:15-25. doi: 10.1111/ijlh.12993. Int J Lab Hematol. 2019. PMID: 31069988 Review.
Cited by
-
High-frequency Contactless Sensor for the Detection of Heparin-Induced Thrombocytopenia Antibodies via Platelet Aggregation.Int J Mol Sci. 2022 Nov 19;23(22):14395. doi: 10.3390/ijms232214395. Int J Mol Sci. 2022. PMID: 36430873 Free PMC article.
References
-
- Matsuo T, Motohashi S, Wanaka K, Walenga JM. Production of anti-platelet factor 4/heparin complex antibodies after cardiovascular surgery. Clin Appl Thromb Hemost. 2015;21(2):177–180. - PubMed
-
- Sheridan D, Caryer C, Kelton J. A diagnostic test for heparin-induced thrombocytopenia. Blood. 1986;67(1):27–30. - PubMed
-
- Asada R, Wanaka K, Walenga J, et al. Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2013;19(1):37–41. - PubMed
-
- Warkentin TE, Greinacher A, Gruel Y, et al. Laboratory testing for heparin-induced thrombocytopenia: a conceptional framework and implications for diagnosis. J Thromb Haemost. 2011;9(12):2498–2500. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous